IL-10 inhibits cytokine production by activated macrophages
- PMID: 1940369
IL-10 inhibits cytokine production by activated macrophages
Abstract
IL-10 inhibits the ability of macrophage but not B cell APC to stimulate cytokine synthesis by Th1 T cell clones. In this study we have examined the direct effects of IL-10 on both macrophage cell lines and normal peritoneal macrophages. LPS (or LPS and IFN-gamma)-induced production of IL-1, IL-6, and TNF-alpha proteins was significantly inhibited by IL-10 in two macrophage cell lines. Furthermore, IL-10 appears to be a more potent inhibitor of monokine synthesis than IL-4 when added at similar concentrations. LPS or LPS- and IFN-gamma-induced expression of IL-1 alpha, IL-6, or TNF-alpha mRNA was also inhibited by IL-10 as shown by semiquantitative polymerase chain reaction or Northern blot analysis. Inhibition of LPS-induced IL-6 secretion by IL-10 was less marked in FACS-purified peritoneal macrophages than in the macrophage cell lines. However, IL-6 production by peritoneal macrophages was enhanced by addition of anti-IL-10 antibodies, implying the presence in these cultures of endogenous IL-10, which results in an intrinsic reduction of monokine synthesis after LPS activation. Consistent with this proposal, LPS-stimulated peritoneal macrophages were shown to directly produce IL-10 detectable by ELISA. Furthermore, IFN-gamma was found to enhance IL-6 production by LPS-stimulated peritoneal macrophages, and this could be explained by its suppression of IL-10 production by this same population of cells. In addition to its effects on monokine synthesis, IL-10 also induces a significant change in morphology in IFN-gamma-stimulated peritoneal macrophages. The potent action of IL-10 on the macrophage, particularly at the level of monokine production, supports an important role for this cytokine not only in the regulation of T cell responses but also in acute inflammatory responses.
Similar articles
-
Regulation of macrophage activation by IL-3. II. IL-3 and lipopolysaccharide act synergistically in the regulation of IL-1 expression.J Immunol. 1990 May 1;144(9):3400-10. J Immunol. 1990. PMID: 2109777
-
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.J Immunol. 1991 May 15;146(10):3444-51. J Immunol. 1991. PMID: 1827484
-
Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.Eur Cytokine Netw. 1997 Jun;8(2):189-201. Eur Cytokine Netw. 1997. PMID: 9262968
-
Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10.Ann N Y Acad Sci. 1993 Jun 23;685:713-39. doi: 10.1111/j.1749-6632.1993.tb35934.x. Ann N Y Acad Sci. 1993. PMID: 8363277 Review.
-
Immunosuppressive and anti-inflammatory properties of interleukin 10.Ann Med. 1995 Oct;27(5):537-41. doi: 10.3109/07853899509002465. Ann Med. 1995. PMID: 8541028 Review.
Cited by
-
CD4+ CD25+ FOXP3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model.Biomed Res Int. 2013;2013:632436. doi: 10.1155/2013/632436. Epub 2012 Dec 26. Biomed Res Int. 2013. PMID: 23509755 Free PMC article.
-
Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.Mediators Inflamm. 2013;2013:165974. doi: 10.1155/2013/165974. Epub 2013 Jun 18. Mediators Inflamm. 2013. PMID: 23853427 Free PMC article. Review.
-
Interleukin-10 promoter polymorphisms and haplotypes in patients with Guillain-Barré syndrome.Ann Clin Transl Neurol. 2024 Jan;11(1):133-142. doi: 10.1002/acn3.51939. Epub 2023 Nov 13. Ann Clin Transl Neurol. 2024. PMID: 37955408 Free PMC article.
-
Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura.Blood Transfus. 2012 Apr;10(2):194-9. doi: 10.2450/2011.0055-11. Epub 2011 Nov 15. Blood Transfus. 2012. PMID: 22153687 Free PMC article.
-
The effect of TLR3 priming conditions on MSC immunosuppressive properties.Stem Cell Res Ther. 2023 Nov 29;14(1):344. doi: 10.1186/s13287-023-03579-y. Stem Cell Res Ther. 2023. PMID: 38031182 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases